重组人促红细胞生成素对急性缺血性脑卒中患者神经保护的研究  

Study on the Neuroprotective Effects of Recombinant Human Erythropoietin in Patients With Acute Ischemic Stroke

作　　者：薛炬君[1] 陈曦[1] 

机构地区：[1]黑龙江省医院老年神经内科,哈尔滨150036

出　　处：《中国卫生标准管理》2016年第4期88-89,共2页China Health Standard Management

摘　　要：目的分析对急性缺血性脑卒中患者实施重组人促红细胞生成素治疗方案后对患者神经的保护作用。方法收集我院接受治疗的该症患者50例,治疗组患者皮下注射重组人促红细胞生成素,对照组患者皮下注射生理盐水。结果治疗组患者的治疗有效率,神经功能缺损改善程度和患者日常生活能力改善程度均高于对照组。结论对患有急性缺血性脑卒中患者实施重组人促红细胞生成素治疗方案可以提高治疗有效率,并有效保护患者神经功能,提高患者日常生活的质量。Objective To analyze the protective effect in implementation of recombinant human erythropoietin on the patients with acute ischemic stroke. Methods 50 patients in our hospital were treated with subcutaneous injection of recombinant human erythropoietin,and the control group were injected with normal saline. Results The treatment group of efficiency,nerve function defect degree and the ability of daily life of patients were higher than that of control group. Conclusion The implementation of recombinant human erythropoietin on the patients with acute ischemic stroke can improve the treatment efficiency,and effectively protect neurological function,improve patients＇ quality of daily life.

关 键 词：重组人促红细胞生成素 急性缺血性脑卒中 神经保护 

分 类 号：R743.3[医药卫生—神经病学与精神病学]